{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,2]],"date-time":"2026-11-02T18:40:34Z","timestamp":1793644834941,"version":"4.5.1"},"reference-count":70,"publisher":"Informa UK Limited","issue":"1","license":[{"start":{"date-parts":[[2023,1,2]],"date-time":"2023-01-02T00:00:00Z","timestamp":1672617600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100020955","name":"GlaxoSmithKline Biologicals SA","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100020955","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100020955","name":"GlaxoSmithKline Biologicals SA","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100020955","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["www.tandfonline.com"],"crossmark-restriction":true},"short-container-title":["Human Vaccines & Immunotherapeutics"],"published-print":{"date-parts":[[2023,1,2]]},"DOI":"10.1080\/21645515.2023.2168952","type":"journal-article","created":{"date-parts":[[2023,3,14]],"date-time":"2023-03-14T08:40:08Z","timestamp":1678783208000},"update-policy":"https:\/\/doi.org\/10.1080\/tandf_crossmark_01","source":"Crossref","is-referenced-by-count":41,"title":["Cost-effectiveness of the recombinant zoster vaccine (RZV) against herpes zoster: An updated critical review"],"prefix":"10.1080","volume":"19","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9130-4744","authenticated-orcid":false,"given":"Nikolaos","family":"Giannelos","sequence":"first","affiliation":[{"name":"GSK, Value Evidence","place":["Wavre, Belgium"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1707-2305","authenticated-orcid":false,"given":"Cheryl","family":"Ng","sequence":"additional","affiliation":[{"name":"GSK, Value Evidence","place":["Singapore, Singapore"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7423-0111","authenticated-orcid":false,"given":"Desmond","family":"Curran","sequence":"additional","affiliation":[{"name":"GSK, Value Evidence","place":["Wavre, Belgium"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"301","published-online":{"date-parts":[[2023,3,14]]},"reference":[{"key":"e_1_3_6_2_1","doi-asserted-by":"publisher","DOI":"10.7326\/AITC201808070"},{"key":"e_1_3_6_3_1","doi-asserted-by":"publisher","DOI":"10.1080\/21645515.2020.1847582"},{"key":"e_1_3_6_4_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpain.2004.06.001"},{"key":"e_1_3_6_5_1","doi-asserted-by":"publisher","DOI":"10.1586\/14737175.7.11.1581"},{"key":"e_1_3_6_6_1","doi-asserted-by":"publisher","DOI":"10.1007\/s40520-019-01374-5"},{"key":"e_1_3_6_7_1","article-title":"Biologics License Application (BLA) approval for Zoster vaccine recombinant","author":"US Food & Drug Administration","year":"2017","unstructured":"US Food & Drug Administration. Biologics License Application (BLA) approval for Zoster vaccine recombinant. Adjuvanted; 2017 [accessed 2022 Jul 6]. https:\/\/www.fda.gov\/media\/108274\/download","journal-title":"Adjuvanted"},{"key":"e_1_3_6_8_1","doi-asserted-by":"publisher","DOI":"10.15585\/mmwr.mm6703a5"},{"key":"e_1_3_6_9_1","doi-asserted-by":"publisher","DOI":"10.15585\/mmwr.mm7103a2"},{"key":"e_1_3_6_10_1","article-title":"Shingrix","author":"European Medicines Agency","year":"2022","unstructured":"European Medicines Agency. Shingrix. Authorisation Details. [accessed 2022 Jul 6]. https:\/\/www.ema.europa.eu\/en\/medicines\/human\/EPAR\/shingrix#authorisation-details-section","journal-title":"Authorisation Details"},{"key":"e_1_3_6_11_1","doi-asserted-by":"publisher","DOI":"10.1080\/14760584.2021.1956906"},{"key":"e_1_3_6_12_1","article-title":"Biologics License Application (BLA) approval for Zoster vaccine","author":"US Food & Drug Administration","year":"2006","unstructured":"US Food & Drug Administration. Biologics License Application (BLA) approval for Zoster vaccine. Live; 2006 [accessed 2022 Jul 6]. http:\/\/wayback.archive-it.org\/7993\/20170722150959\/https:\/\/www.fda.gov\/BiologicsBloodVaccines\/Vaccines\/ApprovedProducts\/ucm132873.htm","journal-title":"Live"},{"key":"e_1_3_6_13_1","article-title":"Zostavax","author":"European Medicines Agency","year":"2022","unstructured":"European Medicines Agency Zostavax. Authorisation Details. [accessed 2022 Jul 6]. https:\/\/www.ema.europa.eu\/en\/medicines\/human\/EPAR\/zostavax#authorisation-details-section","journal-title":"Authorisation Details"},{"key":"e_1_3_6_14_1","unstructured":"Centers for Disease Control and Prevention. Zostavax (Zoster Vaccine Live) recommendations; 2020 [accessed 2022 Jul 15]. https:\/\/www.cdc.gov\/vaccines\/vpd\/shingles\/hcp\/zostavax\/recommendations.html."},{"key":"e_1_3_6_15_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jclinepi.2021.03.001"},{"key":"e_1_3_6_16_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jval.2021.10.008"},{"key":"e_1_3_6_17_1","unstructured":"An Advisory Committee Statement (ACS). National Advisory Committee on Immunization (NACI). Updated recommendations on the use of Herpes Zoster vaccines. 2018 [accessed 2022 May 10]. https:\/\/www.canada.ca\/content\/dam\/phac-aspc\/documents\/services\/publications\/healthy-living\/updated-recommendations-use-herpes-zoster-vaccines-eng.pdf."},{"key":"e_1_3_6_18_1","unstructured":"Institut national de sant\u00e9 publique du Qu\u00e9bec. Avis sur la pertinence d\u2019ajouter la vaccination contre le zona au Programme qu\u00e9b\u00e9cois d\u2019immunisation; 2018 [accessed 2022 May 10]. https:\/\/www.inspq.qc.ca\/publications\/2381."},{"key":"e_1_3_6_19_1","unstructured":"Ortega-Sanchez IR Economics of vaccinating immunocompromised 19\u201349-years-old adults against herpes zoster in the US; 2021 [accessed 2022 May 10]. https:\/\/www.cdc.gov\/vaccines\/acip\/meetings\/downloads\/slides-2021-09-29\/02-ZosterVaccines-OrtegaSanchez-508.pdf."},{"key":"e_1_3_6_20_1","unstructured":"Ultsch B Weidemann F Koch J Siedler A Modellierung von epidemiologischen und gesundheits\u00f6konomischen: Effekten von Impfungen zur Pr\u00e4vention von Herpes zoster; 2017 [access 2022 May 10]. https:\/\/www.rki.de\/DE\/Content\/Infekt\/Impfen\/ImpfungenAZ\/Zoster\/Modellierung_Zoster_Impfung.pdf?__blob=publicationFile."},{"key":"e_1_3_6_21_1","doi-asserted-by":"publisher","DOI":"10.1503\/cmaj.190274"},{"key":"e_1_3_6_22_1","doi-asserted-by":"publisher","DOI":"10.1001\/jamainternmed.2017.7431"},{"key":"e_1_3_6_23_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2018.07.005"},{"key":"e_1_3_6_24_1","doi-asserted-by":"publisher","DOI":"10.1080\/21645515.2018.1558689"},{"key":"e_1_3_6_25_1","doi-asserted-by":"publisher","DOI":"10.7326\/M18-2347"},{"key":"e_1_3_6_26_1","doi-asserted-by":"publisher","DOI":"10.1093\/ofid\/ofz219"},{"key":"e_1_3_6_27_1","doi-asserted-by":"publisher","DOI":"10.1007\/s40258-019-00491-6"},{"key":"e_1_3_6_28_1","doi-asserted-by":"publisher","DOI":"10.1001\/jamainternmed.2018.3200"},{"key":"e_1_3_6_29_1","doi-asserted-by":"publisher","DOI":"10.1080\/21645515.2021.2002085"},{"key":"e_1_3_6_30_1","doi-asserted-by":"publisher","DOI":"10.1186\/s12916-018-1213-5"},{"key":"e_1_3_6_31_1","doi-asserted-by":"publisher","DOI":"10.1007\/s40273-021-01099-2"},{"key":"e_1_3_6_32_1","doi-asserted-by":"publisher","DOI":"10.1080\/21645515.2018.1509645"},{"key":"e_1_3_6_33_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2019.05.006"},{"key":"e_1_3_6_34_1","doi-asserted-by":"publisher","DOI":"10.1007\/s13555-019-0291-4"},{"key":"e_1_3_6_35_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2018.06.049"},{"key":"e_1_3_6_36_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0210005"},{"key":"e_1_3_6_37_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejim.2017.05.015"},{"key":"e_1_3_6_38_1","volume-title":"TreeAge Pro","author":"TreeAge","year":"2022","unstructured":"TreeAge. 2022. TreeAge Pro. Willamstown, MA: TreeAge Software"},{"key":"e_1_3_6_39_1","volume-title":"R: a language and environment for statistical computing","author":"R Core Team","year":"2013","unstructured":"R Core Team. R: a language and environment for statistical computing. Vienna, Austria: R Foundation for Statistical Computing; 2013."},{"key":"e_1_3_6_40_1","unstructured":"Zorginstituut Nederland. Guideline for economic evaluations in healthcare; 2016 [accessed 2022 May 10]. https:\/\/english.zorginstituutnederland.nl\/binaries\/zinl-eng\/documenten\/reports\/2016\/06\/16\/guideline-for-economic-evaluations-in-healthcare\/Guideline+for+economic+evaluations+in+healthcare.pdf."},{"key":"e_1_3_6_41_1","volume-title":"Making choices in health: wHO guide to cost-effectiveness analysis","author":"World Health Organization","year":"2003","unstructured":"World Health Organization. Making choices in health: wHO guide to cost-effectiveness analysis. In: Tan-Torres Edejer T, Baltussen R, Adam T, Hutubessy R, Acharya A, Evans DB, CJL Murray, editors. 2003. Geneva:World Health Organization."},{"key":"e_1_3_6_42_1","unstructured":"Japanese Ministry of Health LaW. Analysis guidelines on cost-effectiveness evaluation in Central Social Insurance Medical Council. 2016. [accessed 2022 Oct 10]. http:\/\/www.mhlw.go.jp\/file\/05-Shingikai-12404000-Hokenkyoku-Iryouka\/0000109789.pdf."},{"key":"e_1_3_6_43_1","unstructured":"Canada\u2019s Drug and Health Technology Agency. Guidelines for the economic evaluation of health technologies: Canada; 2017 [accessed 2022 May 10]. https:\/\/www.cadth.ca\/sites\/default\/files\/pdf\/guidelines_for_the_economic_evaluation_of_health_technologies_canada_4th_ed.pdf."},{"key":"e_1_3_6_44_1","doi-asserted-by":"publisher","DOI":"10.1017\/S0950268808000678"},{"key":"e_1_3_6_45_1","doi-asserted-by":"publisher","DOI":"10.1186\/s12879-016-1898-z"},{"key":"e_1_3_6_46_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1501184"},{"key":"e_1_3_6_47_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1603800"},{"key":"e_1_3_6_48_1","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciab629"},{"key":"e_1_3_6_49_1","volume-title":"Economic evaluation of vaccination for prevention of Herpes Zoster and related complications","author":"Prosser LA","year":"2017","unstructured":"Prosser LA. Economic evaluation of vaccination for prevention of Herpes Zoster and related complications. Atlanta, GA: University of M; 2017."},{"key":"e_1_3_6_50_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa051016"},{"key":"e_1_3_6_51_1","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/cis638"},{"key":"e_1_3_6_52_1","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciu918"},{"key":"e_1_3_6_53_1","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/cir970"},{"key":"e_1_3_6_54_1","doi-asserted-by":"publisher","DOI":"10.1093\/aje\/kwx245"},{"key":"e_1_3_6_55_1","doi-asserted-by":"publisher","DOI":"10.7326\/M15-0093"},{"key":"e_1_3_6_56_1","doi-asserted-by":"publisher","DOI":"10.4161\/hv.4.3.5686"},{"key":"e_1_3_6_57_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2011.09.079"},{"key":"e_1_3_6_58_1","doi-asserted-by":"publisher","DOI":"10.1002\/hec.3513"},{"key":"e_1_3_6_59_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2007.09.066"},{"key":"e_1_3_6_60_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0264-410X(01)00044-5"},{"key":"e_1_3_6_61_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2008.12.024"},{"key":"e_1_3_6_62_1","doi-asserted-by":"publisher","DOI":"10.1503\/cmaj.091711"},{"key":"e_1_3_6_63_1","doi-asserted-by":"publisher","DOI":"10.1007\/s40273-018-0735-1"},{"key":"e_1_3_6_64_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2014.01.058"},{"key":"e_1_3_6_65_1","doi-asserted-by":"publisher","DOI":"10.1080\/13696998.2021.2008195"},{"key":"e_1_3_6_66_1","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/jiw047"},{"key":"e_1_3_6_67_1","doi-asserted-by":"publisher","DOI":"10.1111\/papr.12518"},{"key":"e_1_3_6_68_1","doi-asserted-by":"publisher","DOI":"10.1017\/S0950268811002640"},{"key":"e_1_3_6_69_1","doi-asserted-by":"publisher","DOI":"10.1007\/s40273-012-0020-7"},{"key":"e_1_3_6_70_1","unstructured":"A long-term follow-up study (ZOE-LTFU) of two studies 110390 (ZOSTER-006) and 113077 (ZOSTER-022) to assess the efficacy safety and immunogenicity persistence of GSK biologicals\u2019 Herpes Zoster subunit (HZ\/su) vaccine and assessment of 1 or 2 additional doses in two subgroups of older adults. 2016. [accessed 2022 Oct 10]. https:\/\/clinicaltrials.gov\/ct2\/show\/record\/NCT02723773?view=record."},{"key":"e_1_3_6_71_1","doi-asserted-by":"publisher","DOI":"10.1093\/gerona\/gly150"}],"container-title":["Human Vaccines & Immunotherapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/21645515.2023.2168952","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,9]],"date-time":"2025-05-09T18:25:37Z","timestamp":1746815137000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.1080\/21645515.2023.2168952"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,1,2]]},"references-count":70,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2023,1,2]]}},"alternative-id":["10.1080\/21645515.2023.2168952"],"URL":"https:\/\/doi.org\/10.1080\/21645515.2023.2168952","relation":{},"ISSN":["2164-5515","2164-554X"],"issn-type":[{"value":"2164-5515","type":"print"},{"value":"2164-554X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,1,2]]},"assertion":[{"value":"The publishing and review policy for this title is described in its Aims & Scope.","order":1,"name":"peerreview_statement","label":"Peer Review Statement"},{"value":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=khvi20","URL":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=khvi20","order":2,"name":"aims_and_scope_url","label":"Aim & Scope"},{"value":"2022-09-16","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2023-01-03","order":1,"name":"revised","label":"Revised","group":{"name":"publication_history","label":"Publication History"}},{"value":"2023-01-12","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2023-03-14","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}],"article-number":"2168952"}}